Meta-analysis of external validation studies

Size: px
Start display at page:

Download "Meta-analysis of external validation studies"

Transcription

1 Meta-analysis of external validation studies Thomas Debray, PhD Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands Cochrane Netherlands, Utrecht, The Netherlands

2 Meta-analysis of external validation studies - Introduction Prediction ˆ Turn available information about individuals into a statement about the probability:... of having a particular disease diagnosis... of developing a particular event prognosis ˆ Use of multiple predictors Subject characteristics History and physical examination results Imaging results (Bio)markers ˆ Typical aims to inform patients and their families to guide treatment and other clinical decisions to create risk groups Vigo, July 10, 2017 TPA Debray 2/23

3 Meta-analysis of external validation studies - Introduction What is a good model? Accurate predictions CALIBRATION DISCRIMINATION IMPACT Improve patient outcomes Ability to distinguish between low and high risk patients Good and consistent performance across different settings and populations GENERALITY SUPPORT Influence decision making Vigo, July 10, 2017 TPA Debray 3/23

4 Meta-analysis of external validation studies - Introduction Numerous models for same target population + outcomes 1995 We believe that the main reasons why doctors reject published prognostic models are lack of clinical credibility and lack of evidence that a prognostic model can support decisions about patient care. Wyatt JC, Altman DG. Commentary: Prognostic models: clinically useful or quickly forgotten? BMJ. 1995;311(7019): Vigo, July 10, 2017 TPA Debray 4/23

5 Meta-analysis of external validation studies - Introduction Numerous models for same target population + outcomes Comparing risk prediction models should be routine when deriving a new model for the same purpose Collins GS, Moons KGM. Comparing risk prediction models. BMJ. 2012;344:e3186 e3186. Vigo, July 10, 2017 TPA Debray 5/23

6 Meta-analysis of external validation studies - Introduction Numerous models for same target population + outcomes There is an excess of models predicting incident CVD in the general population. The usefulness of most of the models remains unclear. Damen JAAG, Hooft L, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;353:i2416. Vigo, July 10, 2017 TPA Debray 6/23

7 Meta-analysis of external validation studies - Introduction Numerous models for same target population + outcomes Formal guidance for systematic review and meta-analysis Vigo, July 10, 2017 TPA Debray 7/23

8 Motivating example Previous guidance focused on meta-analysis of logistic regression models. Hence, focus of today is on survival models. Framingham Risk Score (Wilson et al. 1998) ˆ Model type: Cox regression ˆ Outcome: Fatal or non-fatal coronary heart disease (CHD) ˆ Timing: Initial CHD within 10 years ˆ Evidence: 24 validations in male populations Summarize estimates of model performance ˆ Concordance statistic (cstat) ˆ Ratio of observed versus expected events (OE) ˆ Calibration slope (slope) Vigo, July 10, 2017 TPA Debray 8/23

9 Statistical framework - data extraction Key problem: Poor and inconsistent reporting of prediction model performance. Standard error of the c-statistic [ ] c (1 c) 1 + n 1 c 2 c + m c 1+c SE(c) mn with c the reported c-statistic, n the number of observed events, m the total number of non-events and m = n = 1 2 (m + n) 1. Newcombe RG. Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 2: asymptotic methods and evaluation. Stat Med. 2006;25(4): Vigo, July 10, 2017 TPA Debray 9/23

10 Estimated versus reported standard error of the c-statistic EuroSCORE II Framingham Reported standard error Estimated standard error Vigo, July 10, 2017 TPA Debray 10/23

11 Statistical framework - data extraction Ratio of observed versus expected events ˆ Reference value: 1 ˆ Observed survival probability (S KM,t ) ˆ Expected (predicted) event rate (P E,t ) (O:E) t = 1 S KM,t P E,t SE(O:E) t = 1 P E,t SE(S KM,t ) If unavailable, SE(S KM,t ) can be approximated as well: SE(S KM,t ) S KM,t (1 S KM,t ) N t Vigo, July 10, 2017 TPA Debray 11/23

12 Extraction of event rates: an example Vigo, July 10, 2017 TPA Debray 12/23

13 Statistical framework - data extraction Calibration slope ˆ Reference value: 1 ˆ The calibration slope β is calculated as follows using IPD: y k Bernoulli(p k ) logit(p k ) = α + β LP k ˆ When missing, we can derive β from reported event counts across j risk strata (e.g. as presented in calibration tables): O j Binom(N j, p O,j ) logit(p O,j ) = η + β logit(p E,j ) Vigo, July 10, 2017 TPA Debray 13/23

14 Extracted risk estimates for the Framingham Risk Score Observed risk Expected risk The diagonal line indicates perfect calibration. Risk estimates were reported for 5 years follow-up (dashed lines), 7.5 years follow-up (dotted lines) and 10 years follow-up (full lines).

15 Statistical framework - data extraction #validations analysed reported study authors approximated cstat SE.cstat OE slope For 10 studies, calibration performance was only available for < 10 years follow-up. Vigo, July 10, 2017 TPA Debray 15/23

16 Statistical framework - meta-analysis models Meta-analysis of the c-statistic ˆ Need to apply logit transformation logit(c i ) N ( µ discr, Var (logit(c i )) + τdiscr 2 ) ˆ Use delta method to derive Var (logit(c i )) from SE(c i ) ˆ For Bayesian models, we propose weakly informative priors: µ discr N (0, 10 6 ) τdiscr Unif(0, 2) τdiscr Student-t(0, 0.5 2, 3) T [0, 10] based on empirical data from 26 meta-analyses (with ˆτ discr ranging from 0 to 0.50). Vigo, July 10, 2017 TPA Debray 16/23

17 Statistical framework - meta-analysis models Meta-analysis of the c-statistic Estimation K Summary 95% CI 95% PI REML Bayesian (Unif) Bayesian (Student-t) For 3 studies, we did not have information on c i but could nevertheless approximate SE(c i ). Vigo, July 10, 2017 TPA Debray 17/23

18 Statistical framework - meta-analysis models Meta-analysis of the total O:E ratio We can use different models to account for sampling variability: Option 1 ln(o:e) i N ( µ cal.oe, Var (ln(o:e) i ) + τcal.oe 2 ) Option 2 O i Binom (N i, p O,i ) E i Binom (N i, p E,i ) ln (p O,i /p E,i ) N ( µ cal.oe, τcal.oe 2 ) Option 3 O i Poisson (E i exp(η i )) η i N ( µ cal.oe, τcal.oe 2 ) For all models, the interpretation of µ cal.oe and τ cal.oe is the same. Vigo, July 10, 2017 TPA Debray 18/23

19 Statistical framework - meta-analysis models Meta-analysis of the total O:E ratio (c ed) ˆ For Bayesian models, we propose weakly informative priors: µ cal.oe N (0, 10 6 ) τ cal.oe Unif(0, 2) τcal.oe Student-t(0, 1.5 2, 3) T [0, 10] based on empirical data from 16 meta-analyses (with ˆτ cal.oe ranging from 0 to 1.39). ˆ Possible to extrapolate event rates at time l to time t using: ( ) t ln(1 pl ) p t = 1 S KM,t = 1 exp l Straightforward to integrate in Bayesian estimation framework Vigo, July 10, 2017 TPA Debray 19/23

20 Statistical framework - meta-analysis models Meta-analysis of the total O:E ratio Estimation K Summary 95% CI 95% PI REML Bayesian 1 (Unif) Bayesian 1 (Student-t) ML Bayesian 3 (Unif) Bayesian 3 (Student-t) When applying extrapolation, we have 10 additional studies for meta-analysis (similar results). Vigo, July 10, 2017 TPA Debray 20/23

21 Statistical framework - meta-analysis models Meta-analysis of the calibration slope ˆ No transformations needed ˆ Rely on binomial approximation O ij Binom(N ij, p O,ij ) logit(p O,ij ) = α i + β i logit(p E,ij ) β i N (µ cal.slope, τ 2 cal.slope ) ˆ For Bayesian models, we propose weakly informative priors: µcal.slope N (0, 10 6 ) τcal.slope Unif(0, 2) τ cal.slope Student-t(0, 1.5 2, 3) T [0, 10] Vigo, July 10, 2017 TPA Debray 21/23

22 Statistical framework - meta-analysis models Meta-analysis of the calibration slope Estimation K Summary 95% CI 95% PI ML Bayesian Bayesian When applying extrapolation, we have 8 additional studies for meta-analysis (similar results but smaller intervals). Vigo, July 10, 2017 TPA Debray 22/23

23 Meta-analysis of external validation studies - Conclusion Final remarks ˆ Substantial efforts often needed to restore missing information ˆ Bayesian estimation methods recommended to fully propagate uncertainty arising from data restoration ˆ Development of R package metamisc to assist in data preparation and meta-analysis ˆ Presence of statistical heterogeneity most likely ˆ Straightforward extension to meta-regression and multivariate meta-analysis Vigo, July 10, 2017 TPA Debray 23/23

Systematic reviews of prognostic studies 3 meta-analytical approaches in systematic reviews of prognostic studies

Systematic reviews of prognostic studies 3 meta-analytical approaches in systematic reviews of prognostic studies Systematic reviews of prognostic studies 3 meta-analytical approaches in systematic reviews of prognostic studies Thomas PA Debray, Karel GM Moons for the Cochrane Prognosis Review Methods Group Conflict

More information

Systematic reviews of prognostic studies: a meta-analytical approach

Systematic reviews of prognostic studies: a meta-analytical approach Systematic reviews of prognostic studies: a meta-analytical approach Thomas PA Debray, Karel GM Moons for the Cochrane Prognosis Review Methods Group (Co-convenors: Doug Altman, Katrina Williams, Jill

More information

Individual Participant Data (IPD) Meta-analysis of prediction modelling studies

Individual Participant Data (IPD) Meta-analysis of prediction modelling studies Individual Participant Data (IPD) Meta-analysis of prediction modelling studies Thomas Debray, PhD Julius Center for Health Sciences and Primary Care Utrecht, The Netherlands March 7, 2016 Prediction

More information

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges open access External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges Richard D Riley, Joie Ensor, Kym I E Snell, 2 Thomas

More information

Systematic reviews of prediction modeling studies: planning, critical appraisal and data collection

Systematic reviews of prediction modeling studies: planning, critical appraisal and data collection Systematic reviews of prediction modeling studies: planning, critical appraisal and data collection Karel GM Moons, Lotty Hooft, Hans Reitsma, Thomas Debray Dutch Cochrane Center Julius Center for Health

More information

Summarising and validating test accuracy results across multiple studies for use in clinical practice

Summarising and validating test accuracy results across multiple studies for use in clinical practice Summarising and validating test accuracy results across multiple studies for use in clinical practice Richard D. Riley Professor of Biostatistics Research Institute for Primary Care & Health Sciences Thank

More information

Meta-analysis of few small studies in small populations and rare diseases

Meta-analysis of few small studies in small populations and rare diseases Meta-analysis of few small studies in small populations and rare diseases Christian Röver 1, Beat Neuenschwander 2, Simon Wandel 2, Tim Friede 1 1 Department of Medical Statistics, University Medical Center

More information

Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases

Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases Christian Röver 1, Tim Friede 1, Simon Wandel 2 and Beat Neuenschwander 2 1 Department of Medical Statistics,

More information

Meta-analysis of clinical prediction models

Meta-analysis of clinical prediction models Meta-analysis of clinical prediction models Thomas P. A. Debray Julius Center for Health Sciences and Primary Care Utrecht University Meta-analysis of clinical prediction models Julius Center for Health

More information

Development, validation and application of risk prediction models

Development, validation and application of risk prediction models Development, validation and application of risk prediction models G. Colditz, E. Liu, M. Olsen, & others (Ying Liu, TA) 3/28/2012 Risk Prediction Models 1 Goals Through examples, class discussion, and

More information

From single studies to an EBM based assessment some central issues

From single studies to an EBM based assessment some central issues From single studies to an EBM based assessment some central issues Doug Altman Centre for Statistics in Medicine, Oxford, UK Prognosis Prognosis commonly relates to the probability or risk of an individual

More information

Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ

Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ Tutorial in Biostatistics Received: 11 March 2016, Accepted: 13 September 2016 Published online 16 October 2016 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/sim.7141 Meta-analysis using

More information

Advanced IPD meta-analysis methods for observational studies

Advanced IPD meta-analysis methods for observational studies Advanced IPD meta-analysis methods for observational studies Simon Thompson University of Cambridge, UK Part 4 IBC Victoria, July 2016 1 Outline of talk Usual measures of association (e.g. hazard ratios)

More information

Web Extra material. Comparison of non-laboratory-based risk scores for predicting the occurrence of type 2

Web Extra material. Comparison of non-laboratory-based risk scores for predicting the occurrence of type 2 Web Extra material Comparison of non-laboratory-based risk scores for predicting the occurrence of type 2 diabetes in the general population: the EPIC-InterAct Study Outline Supplementary Figures Legend...

More information

Methods for meta-analysis of individual participant data from Mendelian randomization studies with binary outcomes

Methods for meta-analysis of individual participant data from Mendelian randomization studies with binary outcomes Methods for meta-analysis of individual participant data from Mendelian randomization studies with binary outcomes Stephen Burgess Simon G. Thompson CRP CHD Genetics Collaboration May 24, 2012 Abstract

More information

Bayesian meta-analysis of Papanicolaou smear accuracy

Bayesian meta-analysis of Papanicolaou smear accuracy Gynecologic Oncology 107 (2007) S133 S137 www.elsevier.com/locate/ygyno Bayesian meta-analysis of Papanicolaou smear accuracy Xiuyu Cong a, Dennis D. Cox b, Scott B. Cantor c, a Biometrics and Data Management,

More information

Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests

Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests Received: 24 January 2017 Revised: 17 August 2017 Accepted: 7 September 2017 DOI: 10.1002/jrsm.1266 RESEARCH ARTICLE Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival

More information

Methods for evidence synthesis in the case of very few studies. Guido Skipka IQWiG, Cologne, Germany

Methods for evidence synthesis in the case of very few studies. Guido Skipka IQWiG, Cologne, Germany Methods for evidence synthesis in the case of very few studies Guido Skipka IQWiG, Cologne, Germany 17 September 2018 Cochrane Colloquium 2018, Edinburgh, Statistical Methods Group meeting, G. Skipka 2

More information

Models for potentially biased evidence in meta-analysis using empirically based priors

Models for potentially biased evidence in meta-analysis using empirically based priors Models for potentially biased evidence in meta-analysis using empirically based priors Nicky Welton Thanks to: Tony Ades, John Carlin, Doug Altman, Jonathan Sterne, Ross Harris RSS Avon Local Group Meeting,

More information

It s hard to predict!

It s hard to predict! Statistical Methods for Prediction Steven Goodman, MD, PhD With thanks to: Ciprian M. Crainiceanu Associate Professor Department of Biostatistics JHSPH 1 It s hard to predict! People with no future: Marilyn

More information

Multivariate meta-analysis for non-linear and other multi-parameter associations

Multivariate meta-analysis for non-linear and other multi-parameter associations Research Article Received 9 August 2011, Accepted 11 May 2012 Published online 16 July 2012 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/sim.5471 Multivariate meta-analysis for non-linear

More information

Study protocol v. 1.0 Systematic review of the Sequential Organ Failure Assessment score as a surrogate endpoint in randomized controlled trials

Study protocol v. 1.0 Systematic review of the Sequential Organ Failure Assessment score as a surrogate endpoint in randomized controlled trials Study protocol v. 1.0 Systematic review of the Sequential Organ Failure Assessment score as a surrogate endpoint in randomized controlled trials Harm Jan de Grooth, Jean Jacques Parienti, [to be determined],

More information

Introduction to Meta-analysis of Accuracy Data

Introduction to Meta-analysis of Accuracy Data Introduction to Meta-analysis of Accuracy Data Hans Reitsma MD, PhD Dept. of Clinical Epidemiology, Biostatistics & Bioinformatics Academic Medical Center - Amsterdam Continental European Support Unit

More information

Treatment effect estimates adjusted for small-study effects via a limit meta-analysis

Treatment effect estimates adjusted for small-study effects via a limit meta-analysis Treatment effect estimates adjusted for small-study effects via a limit meta-analysis Gerta Rücker 1, James Carpenter 12, Guido Schwarzer 1 1 Institute of Medical Biometry and Medical Informatics, University

More information

Analysis of left-censored multiplex immunoassay data: A unified approach

Analysis of left-censored multiplex immunoassay data: A unified approach 1 / 41 Analysis of left-censored multiplex immunoassay data: A unified approach Elizabeth G. Hill Medical University of South Carolina Elizabeth H. Slate Florida State University FSU Department of Statistics

More information

Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings

Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings Accepted Manuscript Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings R.H.H. Groenwold, K.G.M. Moons, R. Pajouheshnia, D.G. Altman, G.S. Collins,

More information

Methods Research Report. An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy

Methods Research Report. An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy Methods Research Report An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy Methods Research Report An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy

More information

An Empirical Assessment of Bivariate Methods for Meta-analysis of Test Accuracy

An Empirical Assessment of Bivariate Methods for Meta-analysis of Test Accuracy Number XX An Empirical Assessment of Bivariate Methods for Meta-analysis of Test Accuracy Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 54 Gaither

More information

Using Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs

Using Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs Using Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs David Manner, Brenda Crowe and Linda Shurzinske BASS XVI November 9-13, 2009 Acknowledgements

More information

Estimating interaction on an additive scale between continuous determinants in a logistic regression model

Estimating interaction on an additive scale between continuous determinants in a logistic regression model Int. J. Epidemiol. Advance Access published August 27, 2007 Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2007; all rights reserved. International

More information

Applications of Bayesian methods in health technology assessment

Applications of Bayesian methods in health technology assessment Working Group "Bayes Methods" Göttingen, 06.12.2018 Applications of Bayesian methods in health technology assessment Ralf Bender Institute for Quality and Efficiency in Health Care (IQWiG), Germany Outline

More information

A Comparison of Methods of Estimating Subscale Scores for Mixed-Format Tests

A Comparison of Methods of Estimating Subscale Scores for Mixed-Format Tests A Comparison of Methods of Estimating Subscale Scores for Mixed-Format Tests David Shin Pearson Educational Measurement May 007 rr0701 Using assessment and research to promote learning Pearson Educational

More information

Modelling Spatially Correlated Survival Data for Individuals with Multiple Cancers

Modelling Spatially Correlated Survival Data for Individuals with Multiple Cancers Modelling Spatially Correlated Survival Data for Individuals with Multiple Cancers Dipak K. Dey, Ulysses Diva and Sudipto Banerjee Department of Statistics University of Connecticut, Storrs. March 16,

More information

SISCR Module 7 Part I: Introduction Basic Concepts for Binary Biomarkers (Classifiers) and Continuous Biomarkers

SISCR Module 7 Part I: Introduction Basic Concepts for Binary Biomarkers (Classifiers) and Continuous Biomarkers SISCR Module 7 Part I: Introduction Basic Concepts for Binary Biomarkers (Classifiers) and Continuous Biomarkers Kathleen Kerr, Ph.D. Associate Professor Department of Biostatistics University of Washington

More information

Module Overview. What is a Marker? Part 1 Overview

Module Overview. What is a Marker? Part 1 Overview SISCR Module 7 Part I: Introduction Basic Concepts for Binary Classification Tools and Continuous Biomarkers Kathleen Kerr, Ph.D. Associate Professor Department of Biostatistics University of Washington

More information

Multivariate meta-analysis using individual participant data

Multivariate meta-analysis using individual participant data Original Article Received 19 February 2014, Revised 10 October 2014, Accepted 17 October 2014 Published online 21 November 2014 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/jrsm.1129 Multivariate

More information

Using mixture priors for robust inference: application in Bayesian dose escalation trials

Using mixture priors for robust inference: application in Bayesian dose escalation trials Using mixture priors for robust inference: application in Bayesian dose escalation trials Astrid Jullion, Beat Neuenschwander, Daniel Lorand BAYES2014, London, 11 June 2014 Agenda Dose escalation in oncology

More information

Bayesian random-effects meta-analysis made simple

Bayesian random-effects meta-analysis made simple Bayesian random-effects meta-analysis made simple Christian Röver 1, Beat Neuenschwander 2, Simon Wandel 2, Tim Friede 1 1 Department of Medical Statistics, University Medical Center Göttingen, Göttingen,

More information

An Introduction to Bayesian Statistics

An Introduction to Bayesian Statistics An Introduction to Bayesian Statistics Robert Weiss Department of Biostatistics UCLA Fielding School of Public Health robweiss@ucla.edu Sept 2015 Robert Weiss (UCLA) An Introduction to Bayesian Statistics

More information

Statistical Tolerance Regions: Theory, Applications and Computation

Statistical Tolerance Regions: Theory, Applications and Computation Statistical Tolerance Regions: Theory, Applications and Computation K. KRISHNAMOORTHY University of Louisiana at Lafayette THOMAS MATHEW University of Maryland Baltimore County Contents List of Tables

More information

Summary of main challenges and future directions

Summary of main challenges and future directions Summary of main challenges and future directions Martin Schumacher Institute of Medical Biometry and Medical Informatics, University Medical Center, Freiburg Workshop October 2008 - F1 Outline Some historical

More information

The prevalence and history of knee osteoarthritis in general practice: a case control study

The prevalence and history of knee osteoarthritis in general practice: a case control study The Author (2005). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org doi:10.1093/fampra/cmh700 Family Practice Advance Access

More information

AJAE appendix for Defining Access to Health Care: Evidence on the Importance of. Quality and Distance in Rural Tanzania * Heather Klemick

AJAE appendix for Defining Access to Health Care: Evidence on the Importance of. Quality and Distance in Rural Tanzania * Heather Klemick AJAE appendix for Defining Access to Health Care: Evidence on the Importance of Quality and Distance in Rural Tanzania * Heather Klemick Kenneth L. Leonard Melkiory C. Masatu, M.D. October 3, 2008 Note:

More information

Design and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP I 5/2/2016

Design and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP I 5/2/2016 Design and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP233201500069I 5/2/2016 Overview The goal of the meta-analysis is to assess the effects

More information

CHAMP: CHecklist for the Appraisal of Moderators and Predictors

CHAMP: CHecklist for the Appraisal of Moderators and Predictors CHAMP - Page 1 of 13 CHAMP: CHecklist for the Appraisal of Moderators and Predictors About the checklist In this document, a CHecklist for the Appraisal of Moderators and Predictors (CHAMP) is presented.

More information

AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE

AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE Dr Gary S. Collins Professor Douglas G. Altman Centre for Statistics in Medicine University of Oxford TABLE OF CONTENTS LIST OF TABLES... 3 LIST

More information

Hierarchical Bayesian Modeling of Individual Differences in Texture Discrimination

Hierarchical Bayesian Modeling of Individual Differences in Texture Discrimination Hierarchical Bayesian Modeling of Individual Differences in Texture Discrimination Timothy N. Rubin (trubin@uci.edu) Michael D. Lee (mdlee@uci.edu) Charles F. Chubb (cchubb@uci.edu) Department of Cognitive

More information

Kernel Density Estimation for Random-effects Meta-analysis

Kernel Density Estimation for Random-effects Meta-analysis International Journal of Mathematical Sciences in Medicine (013) 1 5 Kernel Density Estimation for Random-effects Meta-analysis Branko Miladinovic 1, Ambuj Kumar 1 and Benjamin Djulbegovic 1, 1 University

More information

Practical Bayesian Design and Analysis for Drug and Device Clinical Trials

Practical Bayesian Design and Analysis for Drug and Device Clinical Trials Practical Bayesian Design and Analysis for Drug and Device Clinical Trials p. 1/2 Practical Bayesian Design and Analysis for Drug and Device Clinical Trials Brian P. Hobbs Plan B Advisor: Bradley P. Carlin

More information

Reporting and Methods in Clinical Prediction Research: A Systematic Review

Reporting and Methods in Clinical Prediction Research: A Systematic Review Reporting and Methods in Clinical Prediction Research: A Systematic Review Walter Bouwmeester 1., Nicolaas P. A. Zuithoff 1., Susan Mallett 2, Mirjam I. Geerlings 1, Yvonne Vergouwe 1,3, Ewout W. Steyerberg

More information

Template 1 for summarising studies addressing prognostic questions

Template 1 for summarising studies addressing prognostic questions Template 1 for summarising studies addressing prognostic questions Instructions to fill the table: When no element can be added under one or more heading, include the mention: O Not applicable when an

More information

Meta-analyses triggered by previous (false-)significant findings: problems and solutions

Meta-analyses triggered by previous (false-)significant findings: problems and solutions Schuit et al. Systematic Reviews (2015) 4:57 DOI 10.1186/s13643-015-0048-9 METHODOLOGY Open Access Meta-analyses triggered by previous (false-)significant findings: problems and solutions Ewoud Schuit

More information

Prediction models for cardiovascular disease risk in the general population: systematic review

Prediction models for cardiovascular disease risk in the general population: systematic review open access Prediction models for cardiovascular disease risk in the general population: systematic review Johanna A A G Damen, 1, 2 Lotty Hooft, 1, 2 Ewoud Schuit, 1, 2, 3 Thomas P A Debray, 1, 2 Gary

More information

Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results

Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results STATISTICS IN MEDICINE Statist. Med. 2008; 27:4617 4633 Published online 4 August 2008 in Wiley InterScience (www.interscience.wiley.com).3144 Estimating HIV incidence in the United States from HIV/AIDS

More information

Beyond RevMan: Meta-Regression. Analysis in Context

Beyond RevMan: Meta-Regression. Analysis in Context Beyond RevMan: Meta-Regression Analysis in Context Robin Christensen, MSc, Biostatistician The Parker Institute: Musculoskeletal Statistics Unit Frederiksberg Hospital Copenhagen, Denmark Statistical Editor

More information

Genetic risk prediction for CHD: will we ever get there or are we already there?

Genetic risk prediction for CHD: will we ever get there or are we already there? Genetic risk prediction for CHD: will we ever get there or are we already there? Themistocles (Tim) Assimes, MD PhD Assistant Professor of Medicine Stanford University School of Medicine WHI Investigators

More information

Sensitivity, specicity, ROC

Sensitivity, specicity, ROC Sensitivity, specicity, ROC Thomas Alexander Gerds Department of Biostatistics, University of Copenhagen 1 / 53 Epilog: disease prevalence The prevalence is the proportion of cases in the population today.

More information

Today: Binomial response variable with an explanatory variable on an ordinal (rank) scale.

Today: Binomial response variable with an explanatory variable on an ordinal (rank) scale. Model Based Statistics in Biology. Part V. The Generalized Linear Model. Single Explanatory Variable on an Ordinal Scale ReCap. Part I (Chapters 1,2,3,4), Part II (Ch 5, 6, 7) ReCap Part III (Ch 9, 10,

More information

Bayesian Dose Escalation Study Design with Consideration of Late Onset Toxicity. Li Liu, Glen Laird, Lei Gao Biostatistics Sanofi

Bayesian Dose Escalation Study Design with Consideration of Late Onset Toxicity. Li Liu, Glen Laird, Lei Gao Biostatistics Sanofi Bayesian Dose Escalation Study Design with Consideration of Late Onset Toxicity Li Liu, Glen Laird, Lei Gao Biostatistics Sanofi 1 Outline Introduction Methods EWOC EWOC-PH Modifications to account for

More information

Bayesian hierarchical modelling

Bayesian hierarchical modelling Bayesian hierarchical modelling Matthew Schofield Department of Mathematics and Statistics, University of Otago Bayesian hierarchical modelling Slide 1 What is a statistical model? A statistical model:

More information

Combining Predictors for Classification Using the Area Under the ROC Curve

Combining Predictors for Classification Using the Area Under the ROC Curve UW Biostatistics Working Paper Series 6-7-2004 Combining Predictors for Classification Using the Area Under the ROC Curve Margaret S. Pepe University of Washington, mspepe@u.washington.edu Tianxi Cai Harvard

More information

Fixed Effect Combining

Fixed Effect Combining Meta-Analysis Workshop (part 2) Michael LaValley December 12 th 2014 Villanova University Fixed Effect Combining Each study i provides an effect size estimate d i of the population value For the inverse

More information

Overview of Multivariable Prediction Modelling. Methodological Conduct & Reporting: Introducing TRIPOD guidelines

Overview of Multivariable Prediction Modelling. Methodological Conduct & Reporting: Introducing TRIPOD guidelines Overview of Multivariable Prediction Modelling Methodological Conduct & Reporting: Introducing TRIPOD guidelines Gary Collins Centre for Statistics in Medicine www.csm-oxford.org.uk University of Oxford

More information

Small-area estimation of mental illness prevalence for schools

Small-area estimation of mental illness prevalence for schools Small-area estimation of mental illness prevalence for schools Fan Li 1 Alan Zaslavsky 2 1 Department of Statistical Science Duke University 2 Department of Health Care Policy Harvard Medical School March

More information

What is probability. A way of quantifying uncertainty. Mathematical theory originally developed to model outcomes in games of chance.

What is probability. A way of quantifying uncertainty. Mathematical theory originally developed to model outcomes in games of chance. Outline What is probability Another definition of probability Bayes Theorem Prior probability; posterior probability How Bayesian inference is different from what we usually do Example: one species or

More information

Empirical assessment of univariate and bivariate meta-analyses for comparing the accuracy of diagnostic tests

Empirical assessment of univariate and bivariate meta-analyses for comparing the accuracy of diagnostic tests Empirical assessment of univariate and bivariate meta-analyses for comparing the accuracy of diagnostic tests Yemisi Takwoingi, Richard Riley and Jon Deeks Outline Rationale Methods Findings Summary Motivating

More information

Discrimination and Reclassification in Statistics and Study Design AACC/ASN 30 th Beckman Conference

Discrimination and Reclassification in Statistics and Study Design AACC/ASN 30 th Beckman Conference Discrimination and Reclassification in Statistics and Study Design AACC/ASN 30 th Beckman Conference Michael J. Pencina, PhD Duke Clinical Research Institute Duke University Department of Biostatistics

More information

Reflection Questions for Math 58B

Reflection Questions for Math 58B Reflection Questions for Math 58B Johanna Hardin Spring 2017 Chapter 1, Section 1 binomial probabilities 1. What is a p-value? 2. What is the difference between a one- and two-sided hypothesis? 3. What

More information

5/10/2010. ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force

5/10/2010. ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force Presentation of Two Draft Reports 17 May 2010 ITC Task Force: Leadership Team Lieven Annemans

More information

Performance Assessment for Radiologists Interpreting Screening Mammography

Performance Assessment for Radiologists Interpreting Screening Mammography Performance Assessment for Radiologists Interpreting Screening Mammography Dawn Woodard School of Operations Research and Information Engineering Cornell University Joint work with: Alan Gelfand Department

More information

Standards for Heterogeneity of Treatment Effect (HTE)

Standards for Heterogeneity of Treatment Effect (HTE) Standards for Heterogeneity of Treatment Effect (HTE) Ravi Varadhan, PhD (Biostat), PhD (Chem.Engg) Chenguang Wang, PhD (Statistics) Johns Hopkins University July 21, 2015 Module 1 Introduction Objectives

More information

PRACTICAL STATISTICS FOR MEDICAL RESEARCH

PRACTICAL STATISTICS FOR MEDICAL RESEARCH PRACTICAL STATISTICS FOR MEDICAL RESEARCH Douglas G. Altman Head of Medical Statistical Laboratory Imperial Cancer Research Fund London CHAPMAN & HALL/CRC Boca Raton London New York Washington, D.C. Contents

More information

Cancer Incidence Predictions (Finnish Experience)

Cancer Incidence Predictions (Finnish Experience) Cancer Incidence Predictions (Finnish Experience) Tadeusz Dyba Joint Research Center EPAAC Workshop, January 22-23 2014, Ispra Rational for making cancer incidence predictions Administrative: to plan the

More information

Some alternatives for Inhomogeneous Poisson Point Processes for presence only data

Some alternatives for Inhomogeneous Poisson Point Processes for presence only data Some alternatives for Inhomogeneous Poisson Point Processes for presence only data Hassan Doosti Macquarie University hassan.doosti@mq.edu.au July 6, 2017 Hassan Doosti (MQU) Inhomogeneous Spatial Point

More information

Correlation and regression

Correlation and regression PG Dip in High Intensity Psychological Interventions Correlation and regression Martin Bland Professor of Health Statistics University of York http://martinbland.co.uk/ Correlation Example: Muscle strength

More information

Downloaded from:

Downloaded from: Hemingway, H; Croft, P; Perel, P; Hayden, JA; Abrams, K; Timmis, A; Briggs, A; Udumyan, R; Moons, KG; Steyerberg, EW; Roberts, I; Schroter, S; Altman, DG; Riley, RD; PROGRESS Group (2013) Prognosis research

More information

Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.

Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. Multivariate meta-analysis using individual participant data Riley, Richard; Price, Malcolm; Jackson, D.; Wardle, M.; Gueyffier, F.; Wang, J.; Staessen, J. A.; White, I. R. DOI: 10.1002/jrsm.1129 License:

More information

EPI 200C Final, June 4 th, 2009 This exam includes 24 questions.

EPI 200C Final, June 4 th, 2009 This exam includes 24 questions. Greenland/Arah, Epi 200C Sp 2000 1 of 6 EPI 200C Final, June 4 th, 2009 This exam includes 24 questions. INSTRUCTIONS: Write all answers on the answer sheets supplied; PRINT YOUR NAME and STUDENT ID NUMBER

More information

Identifying patients with undetected pancreatic cancer in primary care:

Identifying patients with undetected pancreatic cancer in primary care: Research Gary S Collins and Douglas G Altman Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer (Pancreas) Abstract Background Despite

More information

Evidence synthesis with limited studies

Evidence synthesis with limited studies Evidence synthesis with limited studies Incorporating genuine prior information about between-study heterogeneity PSI conference 2018 Dr. Shijie (Kate) Ren, Research Fellow, School of Health and Related

More information

Improved control for confounding using propensity scores and instrumental variables?

Improved control for confounding using propensity scores and instrumental variables? Improved control for confounding using propensity scores and instrumental variables? Dr. Olaf H.Klungel Dept. of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences

More information

Seeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making

Seeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making Seeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making Noah Ivers MD CCFP PhD Family Physician, Women s College Hospital Scientist, Women s College Research

More information

Empirical evidence on sources of bias in randomised controlled trials: methods of and results from the BRANDO study

Empirical evidence on sources of bias in randomised controlled trials: methods of and results from the BRANDO study Empirical evidence on sources of bias in randomised controlled trials: methods of and results from the BRANDO study Jonathan Sterne, University of Bristol, UK Acknowledgements: Tony Ades, Bodil Als-Nielsen,

More information

Bayesian Modeling of Multivariate Spatial Binary Data with Application to Dental Caries

Bayesian Modeling of Multivariate Spatial Binary Data with Application to Dental Caries Bayesian Modeling of Multivariate Spatial Binary Data with Application to Dental Caries Dipankar Bandyopadhyay dbandyop@umn.edu Division of Biostatistics, School of Public Health University of Minnesota

More information

STATISTICAL METHODS FOR DIAGNOSTIC TESTING: AN ILLUSTRATION USING A NEW METHOD FOR CANCER DETECTION XIN SUN. PhD, Kansas State University, 2012

STATISTICAL METHODS FOR DIAGNOSTIC TESTING: AN ILLUSTRATION USING A NEW METHOD FOR CANCER DETECTION XIN SUN. PhD, Kansas State University, 2012 STATISTICAL METHODS FOR DIAGNOSTIC TESTING: AN ILLUSTRATION USING A NEW METHOD FOR CANCER DETECTION by XIN SUN PhD, Kansas State University, 2012 A THESIS Submitted in partial fulfillment of the requirements

More information

Overview. All-cause mortality for males with colon cancer and Finnish population. Relative survival

Overview. All-cause mortality for males with colon cancer and Finnish population. Relative survival An overview and some recent advances in statistical methods for population-based cancer survival analysis: relative survival, cure models, and flexible parametric models Paul W Dickman 1 Paul C Lambert

More information

Bayes-Verfahren in klinischen Studien

Bayes-Verfahren in klinischen Studien Bayes-Verfahren in klinischen Studien Dr. rer. nat. Joachim Gerß, Dipl.-Stat. joachim.gerss@ukmuenster.de Institute of Biostatistics and Clinical Research J. Gerß: Bayesian Methods in Clinical Trials 2

More information

Biostatistics Primer

Biostatistics Primer BIOSTATISTICS FOR CLINICIANS Biostatistics Primer What a Clinician Ought to Know: Subgroup Analyses Helen Barraclough, MSc,* and Ramaswamy Govindan, MD Abstract: Large randomized phase III prospective

More information

Lec 02: Estimation & Hypothesis Testing in Animal Ecology

Lec 02: Estimation & Hypothesis Testing in Animal Ecology Lec 02: Estimation & Hypothesis Testing in Animal Ecology Parameter Estimation from Samples Samples We typically observe systems incompletely, i.e., we sample according to a designed protocol. We then

More information

Designing a Bayesian randomised controlled trial in osteosarcoma. How to incorporate historical data?

Designing a Bayesian randomised controlled trial in osteosarcoma. How to incorporate historical data? Designing a Bayesian randomised controlled trial in osteosarcoma: How to incorporate historical data? C. Brard, L.V Hampson, M-C Le Deley, G. Le Teuff SCT - Montreal, May 18th 2016 Brard et al. Designing

More information

(A) (B) 2019 American Diabetes Association. Published online at

(A) (B) 2019 American Diabetes Association. Published online at Supplementary Figure S1. Risk of bias for all included trials Studies were rated Low Risk of Bias if the study design is unlikely to have little influence over the true outcome; High Risk of Bias if the

More information

TWISTED SURVIVAL: IDENTIFYING SURROGATE ENDPOINTS FOR MORTALITY USING QTWIST AND CONDITIONAL DISEASE FREE SURVIVAL. Beth A.

TWISTED SURVIVAL: IDENTIFYING SURROGATE ENDPOINTS FOR MORTALITY USING QTWIST AND CONDITIONAL DISEASE FREE SURVIVAL. Beth A. TWISTED SURVIVAL: IDENTIFYING SURROGATE ENDPOINTS FOR MORTALITY USING QTWIST AND CONDITIONAL DISEASE FREE SURVIVAL by Beth A. Zamboni BS Statistics, University of Pittsburgh, 1997 MS Biostatistics, Harvard

More information

RAG Rating Indicator Values

RAG Rating Indicator Values Technical Guide RAG Rating Indicator Values Introduction This document sets out Public Health England s standard approach to the use of RAG ratings for indicator values in relation to comparator or benchmark

More information

Karel G.M. Moons UMC Utrecht Julius Center for Health Sciences and Primary Care,

Karel G.M. Moons UMC Utrecht Julius Center for Health Sciences and Primary Care, Prediction Models From development to validation to clinical impact Karel G.M. Moons UMC Utrecht Julius Center for Health Sciences and Primary Care, www.juliuscenter.nl Summary of various papers/consortia

More information

Systematic Reviews and meta-analyses of Diagnostic Test Accuracy. Mariska Leeflang

Systematic Reviews and meta-analyses of Diagnostic Test Accuracy. Mariska Leeflang Systematic Reviews and meta-analyses of Diagnostic Test Accuracy Mariska Leeflang m.m.leeflang@amc.uva.nl This presentation 1. Introduction: accuracy? 2. QUADAS-2 exercise 3. Meta-analysis of diagnostic

More information

Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial

Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Sripal Bangalore, MD, MHA, Chuan-Chuan Wun, PhD, David A DeMicco, PharmD,

More information

Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome

Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome Stephen Burgess July 10, 2013 Abstract Background: Sample size calculations are an

More information

Today Retrospective analysis of binomial response across two levels of a single factor.

Today Retrospective analysis of binomial response across two levels of a single factor. Model Based Statistics in Biology. Part V. The Generalized Linear Model. Chapter 18.3 Single Factor. Retrospective Analysis ReCap. Part I (Chapters 1,2,3,4), Part II (Ch 5, 6, 7) ReCap Part III (Ch 9,

More information

A note on the graphical presentation of prediction intervals in random-effects meta-analyses

A note on the graphical presentation of prediction intervals in random-effects meta-analyses Guddat et al. Systematic Reviews 2012, 1:34 METHODOLOGY A note on the graphical presentation of prediction intervals in random-effects meta-analyses Charlotte Guddat 1*, Ulrich Grouven 1,2, Ralf Bender

More information

Summary HTA. HTA-Report Summary

Summary HTA. HTA-Report Summary Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst

More information